Alexander V. Veselov 😷🎮
banner
alexxxmd.bsky.social
Alexander V. Veselov 😷🎮
@alexxxmd.bsky.social
😷 M.D., Ph.D.
🦠 Institute of Antimicrobial Chemotherapy, Smolensk State Medical University, Russia
🙃 Opinions and spelling mistakes are my own
Long-acting Lipoglycopeptides for the Treatment of Gram-positive Infections in Children
Evidence and Real-life Experience With Dalbavancin and Oritavancin
Anna Gamell, et al.
Pediatric Infectious Disease Journal Publish Ahead of Print, October 07, 2026.
DOI: 10.1097/INF.0000000000005430
October 7, 2026 at 8:24 AM
HIV therapeutics in 2026.
Danilo Bacic Lima et al.
Clinical Microbiology Reviews, 2026.
doi.org/10.1128/cmr....
HIV therapeutics in 2026 | Clinical Microbiology Reviews
SUMMARYThe treatment and prevention of HIV have undergone significant transformations in the 16 years since the last major review of HIV therapeutics published in ASM’s Journal of Virology (A. M. N. T...
doi.org
October 1, 2026 at 6:50 AM
Reposted by Alexander V. Veselov 😷🎮
GOOD NEWS! Researchers have discovered a new antibiotic, known as manikomycin, that may be a bulwark in the fight against drug-resistant superbugs. By attacking the ribosome in a never-before-seen way, manikomycin can evade the existing mechanisms pathogens have developed to resist antibiotics.
September 28, 2026 at 4:00 PM
Reposted by Alexander V. Veselov 😷🎮
Helicobacter & Herpesvirus detection patterns in pediatric gastric biopsies identify Epstein-Barr Virus as a correlate of gastric inflammation

Pediatric gastric biopsies reveal diverse microbes. H. pylori & EBV show the strongest links to inflammation
www.sciencedirect.com/science/arti... #MicroSky
September 23, 2026 at 6:11 PM
Reposted by Alexander V. Veselov 😷🎮
New #IDSAGuidelines! IDSA has released an evidence-based guideline update on antiviral treatment for mild to moderate COVID-19 in infants, children, and adolescents: https://bit.ly/2ScnyDZ
September 23, 2026 at 5:52 PM
Healthcare-Associated Invasive Mould Diseases: From Rapid Diagnostics to Safe and Effective Management
by Sebastien Imbert et al.
J. Fungi 2026, 12(10), 710;
doi.org/10.3390/jof1...
doi.org
September 23, 2026 at 6:59 AM
Natural Product-Inspired Antifungal Drugs Introduced for Human Use from 1872 to August 2026
by Mark S. Butler and Robert J. Capon
www.mdpi.com/2079-6382/15...
www.mdpi.com
September 21, 2026 at 3:27 PM
Reposted by Alexander V. Veselov 😷🎮
Acute #infections have been recently linked to #cancer progression, but they can also elicit #AntiTumor immune responses. This article explores our gaps in understanding how infections differentially skew #immune programs to promote or restrain cancer progression @plosbiology.org 🧪 plos.io/3UYYcMS
September 16, 2026 at 9:04 AM
Diagnosis and Management of Patients with Suspected Left-sided Prosthetic Valve Endocarditis According to Cardiac FDG-PET CT Results
Juan Caceres, et al.
Open Forum Infectious Diseases, ofag580, doi.org/10.1093/ofid...
Diagnosis and Management of Patients with Suspected Left-sided Prosthetic Valve Endocarditis According to Cardiac FDG-PET CT Results
AbstractBackground. Despite advances in echocardiography, the definitive diagnosis of prosthetic valve endocarditis (PVE) has remained difficult. 18F-fluor
doi.org
September 15, 2026 at 3:00 PM
Detection of antibiotic heteroresistance in clinical microbiology: current and emerging methodologies
Damiano Squitieri, et al.
Clinical Microbiology and Infection, 2026.
doi.org/10.1016/j.cm...
Redirecting
doi.org
September 13, 2026 at 7:28 AM
Reposted by Alexander V. Veselov 😷🎮
PDF is available! Its not formatted and its hard to find, but if you scroll down there are several links to the individual sections and each has a PDF link (e.g., where it says "Executive Summary" below)

www.idsociety.org/globalassets...
September 13, 2026 at 1:40 AM
Performance of the Sensititre YeastOne assay compared with EUCAST E.Def 9.4 against Fusarium clinical isolates: focus on voriconazole and amphotericin B
Pao-Yu Chen, et al.
JAC-Antimicrobial Resistance, Volume 8, Issue 5, October 2026, dlag181
doi.org/10.1093/jaca...
Validate User
doi.org
September 12, 2026 at 8:28 AM
A new era of dermatophytes: emerging species, new risk factors, and taxonomic change

Richard C. Summerbell, et al.
Clinical Microbiology Reviews, 2026.
doi.org/10.1128/cmr....
A new era of dermatophytes: emerging species, new risk factors, and taxonomic change | Clinical Microbiology Reviews
SUMMARYThe traditional landscape of dermatophyte infections has changed over the past decade. The emergence and global expansion of Trichophyton indotineae have highlighted the impact of irrational an...
doi.org
September 12, 2026 at 7:19 AM
Decision-Rule Architecture in Fungal Biomarker-Guided Antifungal Stewardship for Critically Ill Adults: A Systematic Review and Candida-Focused Randomised Meta-Analysis

Giuseppe Neri, et al.
J. Fungi 2026, 12(9), 681;
doi.org/10.3390/jof1...
doi.org
September 11, 2026 at 7:13 AM
Hidden Mould in the Air: A Practical Narrative Mini-Review of Invasive Mould Infection Prevention for High-Risk Patients and Clinicians
Angelika Bauer, et al.
Mycoses, 2026; 69:e70224
doi.org/10.1111/myc....
Hidden Mould in the Air: A Practical Narrative Mini‐Review of Invasive Mould Infection Prevention for High‐Risk Patients and Clinicians
Airborne mould spores, including those of the Aspergillus species, are ubiquitous both indoors and outdoors. While they are generally harmless, inhaled spores can cause severe infections, particularl...
doi.org
September 10, 2026 at 9:27 AM
Stewardship Challenges, PK/PD Evidence, and Prescribing
Appropriateness for Recently Approved Antibiotics
in Pediatric Practice
Alessandra Romandini, et al.
Antibiotics 2026, 15, 883
doi.org/10.3390/anti...
doi.org
September 10, 2026 at 9:26 AM
IDSA/ESCMID 2026 Consensus Statements on Staphylococcus aureus Bacteremia: Risk Stratification, Diagnostic Evaluation, and Management of Adults and Children
www.idsociety.org/practice-gui...
Published September 09, 2026
Staphylococcus aureus Bacteremia
www.idsociety.org
September 9, 2026 at 6:31 PM
Antifungal therapy improves microbiome dynamics in inflammatory bowel disease.
Pan, X., Conroy, A., Ngima, T.S. et al.
Nat Med (2026).
doi.org/10.1038/s415...
Antifungal therapy improves microbiome dynamics in inflammatory bowel disease - Nature Medicine
In an prospective observational study of patients with inflammatory bowel disease with oral thrush, the treatment of fluconazole (orogastrointestinal therapy), but not nystatin (oral therapy), led to ...
doi.org
September 3, 2026 at 8:01 AM
Reposted by Alexander V. Veselov 😷🎮
#Antifungal Azole-resistant #Aspergillus infections are becoming a concern in medicine.

A discovery in #GENETICS reveals the role of a long noncoding RNA, afu-182, as a major regulator of Aspergillus fumigatus response to #azole drugs both in vitro and in vivo.

🔗 buff.ly/CbzQu4r
September 2, 2026 at 8:01 PM
Reposted by Alexander V. Veselov 😷🎮
Tutorial: guidance on the use of large language models for medical research

www.nature.com/articles/s41...

#Medx #phd #academic
September 2, 2026 at 6:33 AM
Reposted by Alexander V. Veselov 😷🎮
@thelancet.com when science becomes part of political propaganda, it's the end of the world. Shame on you, Lancet, and whoever that was, Ed Holt.
August 28, 2026 at 6:48 AM
Impact of renal impairment on pharmacokinetics, safety, and tolerability of funobactam, combined with imipenem and cilastatin
Keith A. Rodvold, et al.
AAC 2026
doi.org/10.1128/aac....
ORCID
orcid.org
August 28, 2026 at 6:40 AM
Hepatitis B in Organ Transplantation—Current Evidence and Clinical Gaps
Oscar A. Fernandez-Garcia, et al.
TID 2026
doi.org/10.1111/tid....
Hepatitis B in Organ Transplantation—Current Evidence and Clinical Gaps
Over the past several decades there have been significant advances in nucleos(t)ide analogue (NA) antiviral therapy for hepatitis B virus (HBV) and global expansion of primary prevention through imm.....
doi.org
August 27, 2026 at 7:46 AM